These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35435856)
1. Surveillance After Treatment of Barrett's Esophagus Benefits Those With High-Grade Dysplasia or Intramucosal Cancer Most. Cotton CC; Shaheen NJ; Thrift AP Am J Gastroenterol; 2022 Jul; 117(7):1056-1062. PubMed ID: 35435856 [TBL] [Abstract][Full Text] [Related]
2. Development of Evidence-Based Surveillance Intervals After Radiofrequency Ablation of Barrett's Esophagus. Cotton CC; Haidry R; Thrift AP; Lovat L; Shaheen NJ Gastroenterology; 2018 Aug; 155(2):316-326.e6. PubMed ID: 29655833 [TBL] [Abstract][Full Text] [Related]
3. AGA Clinical Practice Update on Endoscopic Treatment of Barrett's Esophagus With Dysplasia and/or Early Cancer: Expert Review. Sharma P; Shaheen NJ; Katzka D; Bergman JJGHM Gastroenterology; 2020 Feb; 158(3):760-769. PubMed ID: 31730766 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of Radiofrequency Ablation versus Endoscopic Surveillance for Barrett's Esophagus with Low-Grade Dysplasia: A Systematic Review and Meta-Analysis. Klair JS; Zafar Y; Nagra N; Murali AR; Jayaraj M; Singh D; Rustagi T; Krishnamoorthi R Dig Dis; 2021; 39(6):561-568. PubMed ID: 33503615 [TBL] [Abstract][Full Text] [Related]
5. Risk of malignant progression in Barrett's esophagus indefinite for dysplasia. Ma M; Shroff S; Feldman M; DeMarshall M; Price C; Tierney A; Falk GW Dis Esophagus; 2017 Mar; 30(3):1-5. PubMed ID: 28184470 [TBL] [Abstract][Full Text] [Related]
6. The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Hur C; Choi SE; Rubenstein JH; Kong CY; Nishioka NS; Provenzale DT; Inadomi JM Gastroenterology; 2012 Sep; 143(3):567-575. PubMed ID: 22626608 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Radiofrequency Ablation vs. Endoscopic Surveillance for Barrett's Esophagus With Low-Grade Dysplasia: Meta-Analysis of Randomized Controlled Trials. Wang Y; Ma B; Yang S; Li W; Li P Front Oncol; 2022; 12():801940. PubMed ID: 35296005 [TBL] [Abstract][Full Text] [Related]
8. Comparing outcome of radiofrequency ablation in Barrett's with high grade dysplasia and intramucosal carcinoma: a prospective multicenter UK registry. Haidry RJ; Lipman G; Banks MR; Butt MA; Sehgal V; Graham D; Dunn JM; Gupta A; Sweis R; Miah H; Morris D; Smart HL; Bhandari P; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Veitch A; Dhar A; Nyalender D; Ragunath K; Leahy A; Fullard M; Rodriguez-Justo M; Novelli M; Lovat LB Endoscopy; 2015 Nov; 47(11):980-7. PubMed ID: 26126159 [TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Management of Low-Grade Dysplasia in Barrett's Esophagus: Expert Review From the Clinical Practice Updates Committee of the American Gastroenterological Association. Wani S; Rubenstein JH; Vieth M; Bergman J Gastroenterology; 2016 Nov; 151(5):822-835. PubMed ID: 27702561 [TBL] [Abstract][Full Text] [Related]
10. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience. Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526 [TBL] [Abstract][Full Text] [Related]
11. Radiofrequency Ablation Is Associated With Decreased Neoplastic Progression in Patients With Barrett's Esophagus and Confirmed Low-Grade Dysplasia. Small AJ; Araujo JL; Leggett CL; Mendelson AH; Agarwalla A; Abrams JA; Lightdale CJ; Wang TC; Iyer PG; Wang KK; Rustgi AK; Ginsberg GG; Forde KA; Gimotty PA; Lewis JD; Falk GW; Bewtra M Gastroenterology; 2015 Sep; 149(3):567-76.e3; quiz e13-4. PubMed ID: 25917785 [TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation and endoscopic mucosal resection for dysplastic barrett's esophagus and early esophageal adenocarcinoma: outcomes of the UK National Halo RFA Registry. Haidry RJ; Dunn JM; Butt MA; Burnell MG; Gupta A; Green S; Miah H; Smart HL; Bhandari P; Smith LA; Willert R; Fullarton G; Morris J; Di Pietro M; Gordon C; Penman I; Barr H; Patel P; Boger P; Kapoor N; Mahon B; Hoare J; Narayanasamy R; O'Toole D; Cheong E; Direkze NC; Ang Y; Novelli M; Banks MR; Lovat LB Gastroenterology; 2013 Jul; 145(1):87-95. PubMed ID: 23542069 [TBL] [Abstract][Full Text] [Related]
13. Surveillance in patients with long-segment Barrett's oesophagus: a cost-effectiveness analysis. Kastelein F; van Olphen S; Steyerberg EW; Sikkema M; Spaander MC; Looman CW; Kuipers EJ; Siersema PD; Bruno MJ; de Bekker-Grob EW; Gut; 2015 Jun; 64(6):864-71. PubMed ID: 25037191 [TBL] [Abstract][Full Text] [Related]
14. Salvage cryotherapy after failed radiofrequency ablation for Barrett's esophagus-related dysplasia is safe and effective. Sengupta N; Ketwaroo GA; Bak DM; Kedar V; Chuttani R; Berzin TM; Sawhney MS; Pleskow DK Gastrointest Endosc; 2015 Sep; 82(3):443-8. PubMed ID: 25887715 [TBL] [Abstract][Full Text] [Related]
15. Longitudinal outcomes of radiofrequency ablation versus surveillance endoscopy for Barrett's esophagus with low-grade dysplasia. Kahn A; Al-Qaisi M; Kommineni VT; Callaway JK; Boroff ES; Burdick GE; Lam-Himlin DM; Temkit M; Vela MF; Ramirez FC Dis Esophagus; 2018 Apr; 31(4):. PubMed ID: 29036431 [TBL] [Abstract][Full Text] [Related]
16. Patient predictors of histopathologic response after photodynamic therapy of Barrett's esophagus with high-grade dysplasia or intramucosal carcinoma. Yachimski P; Puricelli WP; Nishioka NS Gastrointest Endosc; 2009 Feb; 69(2):205-12. PubMed ID: 18950764 [TBL] [Abstract][Full Text] [Related]
17. Endoscopic radiofrequency ablation or surveillance in patients with Barrett's oesophagus with confirmed low-grade dysplasia: a multicentre randomised trial. Barret M; Pioche M; Terris B; Ponchon T; Cholet F; Zerbib F; Chabrun E; Le Rhun M; Coron E; Giovannini M; Caillol F; Laugier R; Jacques J; Legros R; Boustiere C; Rahmi G; Metivier-Cesbron E; Vanbiervliet G; Bauret P; Escourrou J; Branche J; Jilet L; Abdoul H; Kaddour N; Leblanc S; Bensoussan M; Prat F; Chaussade S Gut; 2021 Jun; 70(6):1014-1022. PubMed ID: 33685969 [TBL] [Abstract][Full Text] [Related]
18. Outcomes after liquid nitrogen spray cryotherapy in Barrett's esophagus-associated high-grade dysplasia and intramucosal adenocarcinoma: 5-year follow-up. Ramay FH; Cui Q; Greenwald BD Gastrointest Endosc; 2017 Oct; 86(4):626-632. PubMed ID: 28235596 [TBL] [Abstract][Full Text] [Related]
19. Management of Dysplastic Barrett's Esophagus and Early Esophageal Adenocarcinoma. Cotton CC; Eluri S; Shaheen NJ Gastroenterol Clin North Am; 2022 Sep; 51(3):485-500. PubMed ID: 36153106 [TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma. Larghi A; Lightdale CJ; Ross AS; Fedi P; Hart J; Rotterdam H; Noffsinger A; Memeo L; Bhagat G; Waxman I Endoscopy; 2007 Dec; 39(12):1086-91. PubMed ID: 17701854 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]